Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Lymphedema Clinical Trials

A listing of Lymphedema medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (4) clinical trials

Propranolol Dose Escalation in Lymphedema in Patients

Lymphatic malformations (LMs) arise from abnormal development of lymphatic vasculature. Primary lymphedema is considered a form of LM. Recently, results in the investigators' laboratory demonstrated that propranolol, a pan beta-adrenergic receptor (AR) antagonist, had cytotoxic and anti-proliferative effects against cells isolated from LM tissues. Preliminary results from treating symptomatic LM ...

Phase

Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China

Breast cancer related lymphedema (BRCL) is a common complication following breast cancer treatment. The incidence of BRCL ranges from 6-50%, depending on the surgical procedure in the axilla and the type of the radiation therapy. BRCL can causes cosmetic deformities, impaired physical mobility, mental discomfort, reduced quality of life and ...

Phase

Treatment of Lymphedema: Application of the Kinesio Taping

First part: To investigate the reliability study of water displacement and circumference measurement and the change in thickness of subcutaneous space measured by sonography and blood flow measured by DRT4 in normal subjects after applying K-tape. Second part: The incidence of breast carcinoma is in the second place in women ...

Phase

Clinical Study With Lymfactin in the Treatment of Patients With Secondary Lymphedema (AdeLE)

This is a Phase II, double-blind, placebo-controlled, multi-centre clinical study, in which 40 patients with breast cancer associated secondary lymphedema will be randomized 1:1 either to Lymfactin (1 x 10E11 viral particles, vp) or placebo (0.9% physiological saline) group. The study product (Lymfactin or placebo solution) will be administered as ...

Phase